Healthcare

Image

Europe Point-of-Care-Testing (POCT) Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Published Report
  • Sep 2022
  • Europe
  • 350 Pages
  • No of Tables: 69
  • No of Figures: 38

Europe Point of Care Testing (POCT) Market, By Products (Instruments, Consumables & Reagents and Others), Application (Blood Glucose, Cardiac Monitoring, Coagulation, Whole Blood Analysis, Vital Sign Monitoring, Infectious Disease Testing, Urine Analysis, Cholesterol Testing and Others), End User (Laboratories, Hospitals, Clinics, Ambulatory Centers, Homecare, Assisted Living Facilities, Pharmacies/Drug Stores and Others), Mode of Testing (Prescription-Based Testing and OTC Testing), Distribution Channel (Direct Sales, Third Party Distributor and Online Sale) - Industry Trends and Forecast to 2029.

Europe Point of Care Testing (POCT) Market

Europe Point of Care Testing (POCT) Market Analysis and Insights

The point of care testing (POCT) is characterized as testing which can be done in close proximity to the patient where a medical decision can be made immediately including the results and monitoring. Increased prevalence of infectious and chronic diseases, improved diagnosis seeking-rate and rising preference for homecare testing are some of the major drivers driving the market growth.

Europe Point of Care Testing (POCT) Market

Europe Point of Care Testing (POCT) Market

However, lack of alignment with test results obtained from laboratories, high cost and lack of trained staff are some of the challenges hampering the market growth.

Europe point of care testing (POCT) market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyzes that the market is growing with a CAGR of 8.8% in the forecast period of 2022 to 2029 and is expected to reach USD 13,085.33 million by 2029.

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Year

2020 (Customizable to 2019-2014)

Quantitative Units

Revenue in USD Million

Segments Covered

By Products (Instruments, Consumables & Reagents and Others), Application (Blood Glucose, Cardiac Monitoring, Coagulation, Whole Blood Analysis, Vital Sign Monitoring, Infectious Disease Testing, Urine Analysis, Cholesterol Testing and Others), End User (Laboratories, Hospitals, Clinics, Ambulatory Centers, Homecare, Assisted Living Facilities, Pharmacies/Drug Stores and Others), Mode of Testing (Prescription-Based Testing and OTC Testing), Distribution Channel (Direct Sales, Third Party Distributor and Online Sale)

Countries Covered

Germany, France, U.K, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Belgium and rest of Europe

Market Players Covered

Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd., Quidel Corporation Trividia Health, Inc., Nova Biomedical, PTS Diagnostics, Trinity Biotech, LumiraDx, Sekisui Diagnostics, Chembio Diagnostics, Inc., BD, Thermo Fisher Scientific Inc., Abbott, Danaher, binx health, inc, QuantuMDx Group Ltd., Werfen, Thermo Fisher Scientific, Abaxis, EKF Diagnostics and Sysmex Europe SE

Market Definition

Point of Care Testing (POCT) is also called with-patient testing and allows physicians to accurately measure real-time, lab-quality diagnostic results within a few minutes as compared to hours. Currently, there are various products available that provide rapid and accurate results and help in patient’s better outcomes which is expected to provide various other opportunities for the market growth. However, lack of alignment in lab results and high cost of POCT products are expected to restrain the market growth in the forecast period.

Europe point of care testing (POCT) market report provides details of market share, new developments, product pipeline analysis and impact of domestic and localized market players that analyzes opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal.

Europe Point of Care Testing (POCT) Market Dynamics

Drivers

  • Increasing prevalence of infectious and chronic diseases

The prevalence of infectious and chronic diseases such as cancer, diabetes and cardiovascular disorder is rapidly increasing across Europe. According to the World Health Organization (WHO), the contribution of chronic diseases was about 60% which accounted for the number of deaths. In Europe, the major reason behind the increasing number of chronic diseases is the increasing number of geriatric population. These increasing rates of the diseases are directly proportional to the market growth of POCT devices as they are used in the diagnosis of almost all diseases. We also know that as health degeneration begins with aging, the rate of chronic diseases and factors associated with them also increase with time. However, with increase in disease rate, the healthcare system and status of health is also improving due to awareness and adoption of POCT devices that help in the diagnosis of multiple chronic diseases thereby, driving the market growth.

For instance,

  • In October 2017, according to a report published in Springer, 85% of deaths in the European Union (EU) were due to chronic diseases including cancer, cardiovascular disease, chronic respiratory disease, diabetes and mental illness

The growing incidences of chronic diseases in Europe with conditions like cancer, asthma and heart disease among others have improved the usage and awareness about early diagnosis of diseases. This awareness made people buy more healthcare premiums including whole body check-ups regularly that includes almost all the tests. At the same time, the population of chronic diseases is rapidly increasing.

 Thus, a major surge in the prevalence of chronic diseases will be acting as a major driver for the market growth as POCT devices can effectively manage the disorder and provide better comfort and treatment for monitoring whenever needed.

  • Improved diagnosis-seeking rate

Improved healthcare professionals and regular training sessions for the professionals conducting tests have contributed to the improved diagnosis rates in the region, which includes an increase in the successful diagnosis of chronic diseases like cancer, cardiovascular disease, type 2 diabetes and others. The rate of diagnosis also increases as the burden of disease increases. Healthcare and IT professionals have the power to decrease the likelihood of error and are making attempts to increase the rate of seeking POCT. Along with that, they also help in determining and detecting the risk associated with it. Perhaps, to improve the rate of diagnosis the IT professionals evaluate the user experience also.

To support the POCT process, a methodology was introduced that includes coverage of management, time spent by professionals for diagnosis and evaluation activities that would help in improving the accuracy rate of the information and help in making better decisions in terms of diagnosis. Thus, the efforts by the healthcare and IT professionals, improved training of healthcare professionals, change in the patient care delivery system and improved diagnosis-seeking rate in the region are leading to the market growth.

  • Rising preference for homecare testing

Increased demand for homecare testing results in reduced error and safety with ensured quality clinical information that will be available at appropriate time and location and also helps to understand the elder case of a medical emergency. The market has been growing due to rising geriatric population thereby, increasing the demand for homecare testing. With the help of cutting-edge modern technologies, home health care costs have been dramatically reduced and people are being helped effectively. Thus, increased preferences for home healthcare services will boost the demand for POCT devices driving the market growth.

Europe Point of Care Testing (POCT) Market

Opportunity

  • Strategic initiatives by the market players

The increase in the prevalence of chronic and infectious diseases in Europe requires new and advanced POCT kits and solutions with improved efficacy rate and reduced cycle time due to rise in the geriatric population and also to improve the healthcare management and diagnostics for quality performance. Major market leaders are engaged in full filling the demands of healthcare professionals and spending their time in research to produce better products, kits and reagents.

These strategic initiatives by the companies including acquisition and focused segment product launches are helping them to expand and enhance the product portfolio of the company which will ultimately lead to more revenue generation. Hence, these strategic initiatives by the market players are acting as an opportunity that is helping them to drive market growth.

Restraint/Challenge

  • Lack of alignment with test results obtained from laboratories

The POCT results when compared with laboratory testing standards can differ and be performed by clinical personnel who are not trained in clinical laboratory sciences. The standardization and other essential criteria cannot be completed by POCT and this is acting as a major challenge for the market growth.

Given the advantages of POCT research, some downsides are not necessarily considered the safest choice. Owing to the sensitivity and precision associated with laboratory analyzers, clinical laboratory personnel are well aware of the analytical methodologies and are more reliable. In comparison, the test carried out by healthcare personnel rather than laboratory qualified persons resulted in mistakes arising from lack of awareness on the significance of quality management and quality assurance procedures. Thus, more precise and accurate results can be expected from laboratory testing as POCT faces challenges to meet all specific standards of testing due to lack of knowledge.

Recent Developments

  • In May 2022, Abbott updated i-STAT software for hospitals and outpatient facilities to provide solution in real-time. The software consists of high efficacy rate, is cost-effective and provides good quality patient care decision-making
  • In May 2022, EKF Diagnostics announced the launch of its new EKF Link digital connectivity solution for the secure management of POC analyzers and associated data on one centralized platform

Europe Point of Care Testing (POCT) Market Scope

Europe point of care testing (POCT) market is segmented into product, application, end user, mode of testing and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Product

  • Instruments
  • Consumables & Reagents
  • Others

Based on product, the market is segmented into instruments, consumables & reagents and others.

Application

  • Blood Glucose
  • Cardiac Monitoring
  • Coagulation
  • Whole Blood Analysis
  • Vital Sign Monitoring
  • Infectious Disease Testing
  • Urine Analysis
  • Cholesterol Testing
  • Others

Based on application, the market is segmented into blood glucose, cardiac monitoring, coagulation, whole blood analysis, vital sign monitoring, infectious disease testing, urine analysis, cholesterol testing and others.

End User

  • Laboratories
  • Hospitals
  • Clinics
  • Ambulatory Centers
  • Home Care
  • Assisted Living Facilities
  • Pharmacies/Drug Stores
  • Others

Based on end user, the market is segmented into laboratories, hospitals, clinics, ambulatory centers, home care, assisted living facilities, pharmacies/drug stores and others.

Mode of Testing

  • Prescription-Based Testing
  • OTC Testing

Based on mode of testing, the market is segmented into prescription-based testing and OTC testing.

 Distribution Channel

  • Direct Sales
  • Third Party Distributor
  • Online Sale

Europe Point of Care Testing (POCT) Market

Based on distribution channel, the market is segmented into direct sales, third party distributor and online sale.

Europe Point of Care Testing (POCT) Market Regional Analysis/Insights      

Europe point of care testing (POCT) market is analyzed and market size insights and trends are provided by product, application, end user, mode of testing and distribution channel.

Countries covered in this market are Germany, France, U.K., Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Belgium and rest of Europe. Germany dominates the Europe point of care testing (POCT) market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the increased awareness regarding POCT devices in the Europe region.

The country section of the report also provides individual market impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, disease epidemiology and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of global brands and their challenges faced due to high competition from local and domestic brands and impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Europe Point of Care Testing (POCT) Market Share Analysis

The point of care testing market competitive landscape provides details by the competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth and application dominance. The above data points provided are only related to the companies' focus on point of care testing market.

Some of the major players operating in this market are Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd., Quidel Corporation Trividia Health, Inc., Nova Biomedical, PTS Diagnostics, Trinity Biotech, LumiraDx, Sekisui Diagnostics, Chembio Diagnostics, Inc., BD, Thermo Fisher Scientific Inc., Abbott, Danaher, binx health, Inc., QuantuMDx Group Ltd., Werfen, Thermo Fisher Scientific, Abaxis, EKF Diagnostics and Sysmex Europe SE, among others.


SKU-

TABLE 1 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 2 EUROPE INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 3 EUROPE INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY VOLUME, 2020-2029 (MILLION UNITS)

TABLE 4 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 5 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 6 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)

TABLE 7 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 8 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 9 GERMANY POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 10 GERMANY INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 11 GERMANY POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 12 GERMANY POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 13 GERMANY POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)

TABLE 14 GERMANY POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 15 U.K. POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 16 U.K. INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 17 U.K. POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 18 U.K. POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 19 U.K. POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)

TABLE 20 U.K. POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 21 FRANCE POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 22 FRANCE INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 23 FRANCE POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 24 FRANCE POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 25 FRANCE POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)

TABLE 26 FRANCE POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 27 SPAIN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 28 SPAIN INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 29 SPAIN POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 30 SPAIN POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 31 SPAIN POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)

TABLE 32 SPAIN POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 33 ITALY POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 34 ITALY INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 35 ITALY POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 36 ITALY POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 37 ITALY POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)

TABLE 38 ITALY POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 39 RUSSIA POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 40 RUSSIA INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 41 RUSSIA POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 42 RUSSIA POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 43 RUSSIA POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)

TABLE 44 RUSSIA POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 45 NETHERLANDS POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 46 NETHERLANDS INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 47 NETHERLANDS POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 48 NETHERLANDS POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 49 NETHERLANDS POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)

TABLE 50 NETHERLANDS POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 51 SWITZERLAND POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 52 SWITZERLAND INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 53 SWITZERLAND POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 54 SWITZERLAND POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 55 SWITZERLAND POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)

TABLE 56 SWITZERLAND POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 57 TURKEY POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 58 TURKEY INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 59 TURKEY POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 60 TURKEY POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 61 TURKEY POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)

TABLE 62 TURKEY POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 63 BELGIUM POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 64 BELGIUM INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 65 BELGIUM POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 66 BELGIUM POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 67 BELGIUM POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)

TABLE 68 BELGIUM POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 69 REST OF EUROPE POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Europe Point-of-Care-Testing (POCT) Market will reach a value of USD 13,085.33 million by 2029 in the forecast period.
The Europe Point-of-Care-Testing (POCT) Market growth rate is 8.8% during the forecast period.
Increasing prevalence of infectious and chronic diseases are the growth drivers of the Europe Point-of-Care-Testing (POCT) Market.
The product, application, end user, mode of testing and distribution are the factors on which the Europe Point-of-Care-Testing (POCT) Market research is based.
Major companies in the Europe Point-of-Care-Testing (POCT) Market arwEurope Point-of-Care-Testing (POCT) Market are By Products (Instruments, Consumables & Reagents and Others), Application (Blood Glucose, Cardiac Monitoring, Coagulation, Whole Blood Analysis, Vital Sign Monitoring, Infectious Disease Testing, Urine Analysis, Cholesterol Testing and Others), End User (Laboratories, Hospitals, Clinics, Ambulatory Centers, Homecare, Assisted Living Facilities, Pharmacies/Drug Stores and Others), Mode of Testing (Prescription-Based Testing and OTC Testing), Distribution Channel (Direct Sales, Third Party Distributor and Online Sale).
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials